The University of Kansas Cancer Center earned National Cancer Institute designation
On Jul. 12, 2012 the University of Kansas Cancer Center earned National Cancer Institute designation. Through efforts initially…
On Jul. 12, 2012 the University of Kansas Cancer Center earned National Cancer Institute designation. Through efforts initially…
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
On Jul. 4, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…
On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…
On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
On Jun. 21, 2012, the European Region of the world was certified as polio-free. Certification followed years of…
On Jun. 13, 2012, in a project led by the Max Planck Institute for Evolutionary Anthropology in Leipzig,…
On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
On Jun. 5, 2012, an international team of scientists decoded genome of Chagas disease. Previously, scientists had only…
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
May 22, 2012, AZBio led a cross industry coalition to amend Arizona’s Open Records Law to make the…
ON May 16, 2012, the U.S. Senate unanimously passed a resolution (S. Res. 286) recognizing May 16, 2012,…
On May 1, 2012, the U.S. Food and Drug Administration (FDA) approved new orphan drug Elelyso to treat…
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. By Jun. 16, the…
On Mar. 29, 2012, Siemens, now Sivantos, introduced Eclipse , an ultra discreet completely-in-the-canal hearing instrument. The history…
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
On Mar. 27, 2012, the Oregon National Primate Research Center at OHSU dedicated a new home for its…
On March 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
On Mar. 21, 2012, the University of Washington Medical Center became the first in Pacific Northwest to discharge…
On Mar. 8, 2012, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a five-year, $21 million…
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…
On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…